ArticleEuropean journal of clinical pharmacology2023

Variation of tafamidis plasma levels during the treatment of TTR amyloidosis patients with Glu89Gln mutation.

M Smerikarova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.